Transcriptomics Technologies Market Worth $6.9 Billion By 2022

The global transcriptomics technologies market is expected to reach USD 6.9 billion by 2022, according to a new report by Grand View Research Inc. The increasing demand for genetic identification and growing investment in R&D innovation along with the technological advancements across the product portfolio are the vital driving forces of this market. The increasing R&D investments are expected to highly influence biotechnological research and develop commercialization over the forecast period. The rising investment is further anticipated to ensure positive growth and enhance business opportunities for pharmaceutical and biotechnological companies.

Furthermore, the rising demand for efficient diagnostic methods drives the need for personalized medicines. Transcriptomics tools and the offered services identify potential drug targets, which are effective methods for diagnostic methodologies. The shifting preference of pharmaceutical companies towards therapeutics results in rising demand for disease-specific biomarker identification. This change ensures a potential opportunity in the commercialization of transcriptome research results. The escalating demand for efficient diagnostics and treatment measures in the areas of oncology, HIV, Alzheimer’s disease, etc., also contributes significantly towards transcriptomics technologies market growth.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/transcriptomics-technologies-market

Further key findings from the report suggest:

Polymerase Chain Reaction (PCR) based transcriptomics technologies market is expected to account for over 40% market share by 2022 owing to its ability to enable amplification even from very small amounts of genetic material samples
Next-generation Sequencing based transcriptomics technologies market is expected to grow at a lucrative CAGR of over 17.0% over the forecast period owing to increased outsourcing of sequencing technologies, upgrading of technology enabling the analysis of cellular transcriptome from various dimensions, and wide application areas of NGS
North America dominates the transcriptomics technologies market in terms of revenue owing to the increasing R&D activities by the biotechnology and pharmaceutical companies
North America and Asia Pacific are expected to witness the fastest growth of over 15.0% during the forecast period. The growth is due to the presence of untapped opportunities, rising expenditure levels, and the introduction of favorable government initiatives.
Key players of transcriptomics technologies market include Agilent Technologies, Affymetrix, Thermo Fisher Scientific, Illumina, Life Technologies, and F. Hoffmann-La Roche
Market participants are constantly engaged in strategic collaborations such as mergers and acquisitions along with technological advancements in an attempt to improve presence and ensure sustainability
For instance, in May 2015, Agilent Technologies announced the acquisition of Cartagenia that provides services and software for clinical genetic analysis. Their products are supplied to pathology laboratories and clinical research institutes. The acquisition is expected to provide higher integration and support customer satisfaction.

Marine Propulsion Engines Market Is Expected to Reach USD 10.95 Billion by 2020

The Global Marine Propulsion Engines Market is expected to reach USD 10.95 billion by 2020, according to a new study by Grand View Research, Inc. Significant modernization in marine propulsion as a direct consequence of increased demand for operationally dependable and financially efficient ships is expected to drive the marine propulsion engines market. The shipping industry has started to focus more on reducing fossil fuel consumption by developing electric motors which also help increase energy efficiency.

The market is expected to be hindered by regulations of the International Convention for the Prevention of Pollution from Ships (MARPOL), which apply principally to the protection of the marine environment and prevention of contamination by oil, chemical spills, sewage, marine species, and air pollution by engine exhaust gases. With the advancement in technology and increasing awareness pertaining to environmental conservation, the development of propulsion systems that run on alternate fuels and with minimal emissions has garnered special importance.

Although wind and solar energy have gained prominence as auxiliary propulsion sources in the marine propulsion engines market, they are inadequate to suffice the power requirements for primary propulsion purposes.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/marine-propulsion-engines-market

Further key findings from the study suggest:

High reliability and easy operability have resulted in diesel engines being the most extensively used to meet the primary as well as auxiliary ship propulsion needs in the marine industry. The presence of well-established spare parts and repair networks globally coupled with the availability of trained engineers and established training facilities has further driven the diesel marine propulsion engine demand.
The depleting conventional and shale gas reserves have led to an increase in the demand for liquefied natural gas (LNG) as a marine fuel, which involves dual fuel diesel (DFD) engines as prime movers. Wind energy and solar energy have gained prominence as auxiliary power generating sources as they do not emit harmful pollutants. Although steam turbine systems were traditionally used as prime movers, they have been increasingly substituted by diesel and dual-fuel diesel (DFD) engines. Steam marine propulsion engines are still used in niche applications such as coal carriers and LNG carriers.
Asia Pacific accounted for a substantial share of the overall marine propulsion engine market revenue in 2013, which can be attributed to significant investments by countries in the Far East such as China and South Korea. North America is among the highest adopters of LNG as a propulsion medium.
Leading marine propulsion engine manufacturers such as Wärtsilä, Rolls-Royce, MAN Diesel, Caterpillar, and Cummins adopt global multi-sourcing strategies to explore alternative sources of supply. Marine propulsion engines manufacturers have dedicated professional sales staff having expertise in the company’s entire product lines for identifying specific and tailored solutions. The marine propulsion engines market is characterized by frequent mergers and acquisitions in a bid to achieve a competitive advantage.

Automotive lighting market to grow at 12.0% CAGR from 2015 to 2022

The automotive lighting market is anticipated to reach USD 34.65 billion by 2022. Strict government policies and rising safety concerns are likely to propel growth over the forecast period. In addition, growing consumer awareness concerning the significance of adaptive lighting including dynamic bend light and a glare-free high beam is also expected to have a positive impact on the exterior lighting market.

Increasing apprehensions about using energy-efficient methods coupled with rising consumer disposable income are expected to drive the industry. In addition, growing demand for vehicles and technological advancements in the automotive industry is expected to propel utilization. Attractive growth opportunities for new entrants are expected in the industry owing to the growing number of total vehicles purchased y-o-y across BRIC nations. However, there is a need for legislative authorities to collaborate with light sourcing technology suppliers to develop flexible design techniques.

THE Automotive LED market is estimated to demonstrate considerable growth at a CAGR of over 12.0% from 2015 to 2022. Halogen lights contributed to over 66.0% of overall industry revenue in 2014, followed by LED and xenon. It has gained prominence on account of easy availability, low purchasing costs, and low replacement costs. However, rising fuel prices are expected to pose a threat to the industry.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/automotive-lighting-market

The increase in demand for eco-friendly LED technologies on account of high efficiency, reduced CO2 levels, and high power, is expected to propel growth. Companies have been trying to develop eco-friendly LEDs to promote product differentiation and strengthen their global foothold. LEDs are used in daytime running lights (DRL), parking light, brake lights, and turning lights. LEDs are preferred over xenon and halogen lights owing to optimum light-bearing capacities and improved design, which lead to increased shelf life.

The adaptive headlight is an active safety feature that is intended to enhance the drivers’ visibility in poorly illuminated areas. It encompasses functionalities including automatic rotation which can sync with sensors and adjust brightness and intensity of light. The front lighting segment accounted for over 70.0% of the total revenue in 2014 owing to the availability of advanced features including automatic rotation which can sync with automatic brightness modules and sensor response. Extreme climatic conditions in Europe and North America are expected to trigger demand for fog lights over the forecast period.

The automotive lighting industry in Asia Pacific is estimated to grow at a CAGR of over 8.0% and acquire a market share of about 45.0% over the forecast period. The continuous expansion of suppliers coupled with a vast production base is expected to position this region as the market leader. Countries including India, Japan, and China account for the major production base for vehicles globally, thus offering extensive growth opportunities.

Key companies including Hella KGaA Hueck & Co., Koito Manufacturing Co., Magneti Marelli S.p.A and Valeo. Vendors usually employ the strategy of new product development and mergers & acquisitions to enter new markets. The introduction of low-cost LEDs and energy-efficient alternatives is foreseen as a cost-effective strategy for the industry.

Pharmacy automation devices market to grow at 7.3% CAGR in 2020

Pharmacy automation involves automation and mechanization of tasks that include distribution and handling medication processes carried out in heath care centers and specialty pharmacy centers. The global pharmacy automation devices industry is projected to grow at a CAGR of 7.3% from 2014 to 2020 and reach over USD 8.99 billion.

Automation systems such as packaging and labeling systems, medication dispensing system, storage and retrieval systems, table-top counters and compounding systems are employed in order improve the efficacy of regular jobs within pharmacies. The market is expected to grow owing to features including system integration that increases productivity and time to clinicians for patient care, thereby lowering medication errors.

Rising demand for pharmaceutical products, progressively growing technology and demand for precise robotic equipment & tools to perform operations at a faster rate are expected to be the key factors for market growth. Untapped growth opportunities in countries such as Brazil, China, and India coupled with escalating demand for automation in pharmacy and healthcare operations is expected to drive growth over the forecast period.

The market was dominated by automated medication dispensing systems in 2013. It accounted for a share of over 47.8% owing to growing demand for accurate medication dispensing systems. Automated dispensing systems have the ability to reduce significantly error rates and the ability to dispense hands-free. They provide storage, recording of medication, distribution to resident care and computer controlled dispensation.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/pharmacy-automation-market

Automated compounding systems are anticipated to grow rapidly at a CAGR of 8.4% from 2014 to 2020 owing to an increasing demand for mixing of medication and substantial decrease in total time to complete a dose.

The existence of IT healthcare systems and high rate of penetration in healthcare and pharmaceutical units resulted in North America occupying the largest regional market in 2013. It accounted for about 54.8% of the market revenue. Increasing healthcare overheads and R&D relevant to pharmacy automation devices are few factors responsible for its market share.

Asia Pacific is likely to grow at a CAGR of over 9.0% during the forecast period and is the most lucrative regional markets majorly due to improving healthcare infrastructure in emerging economies of China and India. Easy access available to new entrants including multinational pharmaceutical companies and distributors in this region coupled with the introduction of healthcare reforms in these countries is expected to drive market growth.

Key industry players include AmerisourceBergen Corporation, CareFusion Corporation, Accu-Chart Healthcare, ForHealth Technologies, GSE Scale Systems, Fulcrum Inc,McKesson Corporation, Innovation PharmaAssist Robotics, Pearson Medical Technologies, Health Robotics SRL, Kirby Lester, MedDispence, Pyxis Pharmacy Automation Systems, Medacist, MTS Medication Technologies, OmnicellInc, Cerner Corporation, Rice Lake Weighing Systems, Baxter International Inc., Aesynt Inc., ScriptPro LLC, Parat Systems Pharmacy Automation, Yuyama Co. Ltd, Swisslog Holding Ltd,Talyst Inc. and ScriptPro LLC.

Peripheral Vascular Devices Market Size Worth $8,918.8 Million By 2020

The global peripheral vascular devices market is expected to reach USD 8,918.8 million by 2020, growing at an estimated CAGR of 7.2% from 2014 to 2020, according to a new study by Grand View Research, Inc. Peripheral vascular devices such as IVC filters, angiography catheters, and plague modification devices are used for treating peripheral arterial or coronary arterial diseases caused due to the formation of atherosclerotic plaques in arteries. These devices are used to decrease the interference of patients with a minimum disturbance during the surgical procedure.

Increasing incidence of target diseases due to rising geriatric population, extensive presence of both private and public external funding programs, and changing lifestyle and eating habits are expected to be key driving factors for this market over the next six years. In addition, the presence of untapped growth opportunities in emerging markets such as India, Brazil, and China and increasing health awareness are also expected to serve this market as future growth opportunities.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/peripheral-vascular-devices-market

Further key findings from the study suggest:

Peripheral vascular stents dominated the peripheral vascular devices market in terms of share at over 30.8% in 2013; driven by increasing demand for drug-eluting and bio-absorbable stents. Moreover, the ability of these devices to significantly reduce restenosis rates is expected to boost product demand.
The embolic protection devices market is expected to grow at the fastest CAGR of 9.2% during the forecast period; owing to increasing demand for a minimally invasive endovascular surgical method for removing atherosclerosis from large blood vessels.
North America was the largest regional market in 2013, accounting for 40.3% of the global revenue. The presence of sophisticated healthcare infrastructure, high patient awareness levels, healthcare expenditure and high R&D pertaining to drug discovery and development are some of the factors accounting for its large share.
Asia Pacific peripheral vascular devices market is expected to grow at the fastest CAGR of 10.0% from 2014 to 2020; primarily owing to the wide presence of unmet medical needs coupled with rapidly improving healthcare infrastructure in emerging markets of India and China.
Key industry participants of this market include Abbott Laboratories, Angioscore Inc., Edward Lifesciences Corporation, Medtronic Inc., St. Jude Medical, Teleflex Medical, Volcano Corporation, Boston Scientific Corporation, Teleflex Medical, Cook Group Inc., Cordis Corporation, Covidien, W.L.Gore and Associates Ltd., and Angioscore Ltd.

Home Energy Management Systems Market Worth $2 Billion By 2020

The global home energy management systems (HEMS) market is expected to exceed USD 2 billion by 2020, according to a new study by Grand View Research, Inc. Owing to increasing energy cost coupled with growing environmental concerns, energy management has emerged as a significant priority, which is expected to fuel the HEMS market. The need to conserve and optimize energy utilization is expected to serve as a key market driver. Increased connectivity and widespread adoption of smartphones is also expected to favorably impact the market growth. Energy management products demand has gained momentum over the last few years owing to use of variable pricing schemes offered by service providers. Favorable regulatory initiatives in the U.S. pertaining to energy conservation are expected to propel regional HEMS market growth.

High installation cost coupled with system complexity is expected to pose a challenge to market growth over the forecast period. Lack of consumer awareness regarding home energy management systems and the benefits they offer may also hinder the HEMS market. Technological proliferation along with decreased sensor and display costs, improved device-level information processing capability, and roll-out of smart utility meters provide avenues for market growth.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/smart-home-energy-management

Further key findings from the study suggest:

Wi-Fi emerged as the dominant segment in 2013; it is expected to continue accounting for considerable market share over the forecast period. ZigBee, a standard for wireless networks, is expected to be a high growth segment over the forecast period. This can be attributed to its ability to support needs of various utilities, government groups and product manufacturers.
The HEMS market is dominated by control devices and systems; these include thermostats, whole home lighting systems and home automation systems. Enabling technologies are expected to witness high growth over the next six years due to popularity of technologies such as home area network, ZigBee and sensing.
On account of favorable government initiatives and growing need to address issues related to aging infrastructure, North America is expected to emerge as the most dominant regional market over the forecast period. Smart meter mandates by utilities is primarily expected to drive the HEMS market in Europe.
Key market participants include Intel Corporation, Panasonic Corporation, Cisco Systems Inc, General Electric Co. and Honeywell International. Innovations and extensive product development are expected to be the key growth strategies over the forecast period.

Bioinformatics Market Size To Reach $13.47 Billion By 2020

The global bioinformatics market is expected to reach USD 13.47 billion by 2020 growing at an estimated CAGR of 21.2% from 2014 to 2020, according to a new report by Grand View Research, Inc. Growing clinical development of biopharmaceutical and increasing need for three-dimensional drug designing technology are expected to drive the market growth over the next five years.

Furthermore, the development of bioinformatics tools and analysis platforms coupled with the introduction of novel technologies are expected to be high impact rendering factors for the growth of this market. Increasing demand for faster development of novel API and biopharmaceuticals is also expected to enhance the growth of this industry.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/bioinformatics-industry

Growth in the number of research and development studies in various ‘-omics’ related segments and the need for integration of the large amounts of biological data generated from these studies are also expected to encourage industry players to develop faster, more efficient, and versatile bioinformatics software cum platforms for commercialization.

Bio-content processing accounted for over 47% of the revenue share in 2013. The presence of increasing market demand for genetic database management, and need for related sequence, structural and phylogenic analysis tools and software is the primary factor accounting for this large share.

Moreover, the sequence and structural analysis platform segment is expected to grow at the fastest CAGR of over 20% over the forecast period owing to the development of next-generation sequencing and expected reduction in the cost of whole genome exome sequencing. These factors are expected to have a significantly positive impact on the overall growth of this market in the next five years.

Chemo-informatics and genomics accounted for over 50% of revenue share in 2013. Growing demand for novel biomarkers for R&D of biosimilar drugs and biopharmaceuticals is expected to significantly enhance the market penetration over the forecast period.

Proteomic applications are expected to attract a considerable amount of R&D investment in the near future and witness lucrative growth over the forecast period. Developments in three-dimensional drug development technologies are further expected to boost the growth of this segment.

North America accounted for over 40% of the global revenue in 2013. Factors accounting for this large share include the presence of key pharmaceutical companies in the region, which are involved in the clinical development of novel APIs and biosimilar drugs. The presence of a technologically advanced healthcare R&D framework also enhances this region’s investment capabilities for the development of the aforementioned market segments.

Asia Pacific is expected to register the fastest CAGR over the forecast period owing to the presence of companies providing outsourcing services. Furthermore, the presence of high unmet industry needs is expected to be a major factor driving the growth of this region over the forecast period.

Key players in this industry include IBM Life Sciences, BIOVIA, Life Technologies Corporation, Agilent technologies, 3^rd Millennium Inc., Celera Corporation, Affymetrix, BioWisdom Ltd., and Rosetta Biosoftware.

Atrial Fibrillation Market Analysis By Procedure And Segment Forecasts To 2020

The global atrial fibrillation market is expected to reach USD 16.17 billion by 2020. Rising occurrence of strokes, brain damage and atrial fibrillation owing to blood clots along with an increasing geriatric population is expected to drive industry growth. Technological advancements in the field of microwave catheter ablation and radiofrequency along with rising occurrence of diseases caused by lifestyle habits such as drinking and smoking are further expected to fuel growth. Moreover, increasing demand for smaller cardiac incisions, minimally invasive procedures and small recovery time post-surgery are projected to bolster growth. Also, global aging population combined with the changes in lifestyle increasing the risks of obesity and high blood pressure is likely to drive demand.

Pharmacological products accounted for over 50% market share in 2013. Low prices of these products along with increasing use of anti-coagulants as an add-on therapy to non-pharmacological procedures are expected to drive demand.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/atrial-fibrillation-treatment-industry

Further key findings from the report suggest:

North America accounted for over 40% of global revenue in 2013. High penetration of non-pharmacological procedure and sophisticated reimbursement frameworks has resulted in its substantial demand over the past few years. High patient awareness and healthcare expenditure levels also contributed significantly towards region growth.
Asia-Pacific is expected to witness substantial growth during the forecast period, growing at a CAGR of over 13% from 2015 to 2022. Rising demand for non-pharmacological treatments due to improvement in healthcare infrastructure, high disposable incomes, and growing patient awareness are a few factors accounting for its rapid growth.
Radiofrequency catheter ablation procedure segment is expected to be the fastest growing segment with a CAGR of over 12% over the forecast period. Technological advancements related to maneuverability which helps in making tight bends inside the heart, the optimal size of the lesion produced and lower time required to recover from of catheter ablation is expected to drive demand over the next seven years.
Maze surgery occupied the second largest share of non-pharmacological treatment market. It removes the need for life-long anti-coagulants based treatment while reducing the occurrence of strokes. Anti-coagulants held the dominant market share in pharmacological treatment market as it reduced the incidence of blood clots and strokes which in turn is likely to propel demand over the projected period.
Key industry players include Boston Scientific Corporation, St. Jude Medical Inc., Johnson & Johnson Ltd., Sanofi-Aventis, CardioFocus Inc., Boehringer Ingelheim GmbH, Bristol-Myers Squibb Corporation, Biosense Webster Inc., AtriCure Inc. and Endoscopic Technologies Inc. St. Jude Medical Inc. developed an Endosense’sTactiCath. The technology provides live feedback related to pressure applied during microwave catheter ablations and radiofrequency.

Incontinence and Ostomy Care Products Market Analysis By Product And Segment Forecasts To 2020

In 2012, the global incontinence and ostomy care products market was worth USD 11.50 billion. Rising aging population, increasing incidences of obesity and mounting cases of unmet medical conditions of patients are few of the factors driving the market demand.

Prevalent cases of incontinence, ulcerative colitis, inflammatory bowel diseases, Chrohn’s disease, rising health concerns and increasing patient awareness are some other factors leading to an increase in the demand for incontinence and ostomy care products.

Increasing geriatric population is anticipated to drive the overall growth of the incontinence and ostomy care products market. As per the estimates of the World Health Organisation (WHO), global population aged over 65 years is expected to rise from 780 million in 2010 to 975 million in 2017. Thus, growth in geriatric population is expiated to result in rise in target population. According to another report from WHO, women are found more susceptible to incontinence compared to men. Therefore, women are expected to dominate the customer base of the overall market.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/incontinence-and-ostomy-care-products-industry

On the other hand, rising incidents of obesity, high acceptance & awareness among men population is expected to propel the growth of incontinence and ostomy care products market. As a result, the global market is expected to be valued at USD 17.2 billion by 2020.

Presently cleaners, absorbents, deodorizers, incontinence bags, clamps and urinals are widely used as incontinence care products. Absorbents segment dominated the global market with market share of more than 90 % in 2012 since, it is the most popular and commonly used product. Introduction of user friendly, personalized and innovative absorbents coupled with social acceptance of these products will drive the market growth significantly. Therefore, absorbents segment is anticipated grow at the fastest CAGR of 6 % during the period 2013-2020.

Ostomy care products mainly include skin barriers, deodorants, ostomy bags, ilestomy and irrigation products and urostomy bags. In 2012, ostomy bags held the majority of the overall ostomy care products market with a share of over 70%. Rising prevalence of diseases such as Chrohn’s disease, inflammatory bowel disease, coupled with rising elderly population some of the primary factors boosting the growth of the market. In addition, availability of improved products such as user friendly and skin friendly bags are expected to fuel the demand for ostomy bags. Colostomy bags was the leading segment with market share of around 37% with market revenue valued worth USD 1.04 billion in 2012.

Based on the region, the global incontinence and ostomy care market is segmented into North America, Europe, Asia Pacific and Rest of the World. North America captured approximately 37% of the global market share in 2012. Higher disposable incomes, increased awareness regarding side effects of obesity, higher geriatric population in North America are the major factors resulting in dominance of the region in the global incontinence and ostomy care products market.

However, Asia Pacific is anticipated to show fastest growth with CAGR of 7.6 % during 2013-2020. Large geriatric population base in Japan and China, increasing social acceptance and rising popularity of incontinence and ostomy care products in emerging economies including India and China are amongst few factors driving the market growth in Asia Pacific. Key competitors in the market are Unicharm Corporation, Kimberly-Clark Corporation, Hollister Inc., Coloplast Corporation and SCA(Svenska CellulosaAktiebolaget).

Chromium Phosphate Market Size To Reach $96.65 Million By 2020

The global chromium phosphate market is expected to reach USD 96.65 million by 2020, according to a new study by Grand View Research, Inc. Key application markets for chromium phosphate include architectural coatings, corrosion inhibitor coatings, medical applications, and others such as catalyst applications. Strong demand from architectural coatings and corrosion inhibitor coatings are expected to drive chromium phosphate demand over the next six years. Additionally, increasing R&D for chromium phosphate application development in the field of medicine is being looked upon as a key opportunity for this market.

Sourcing of raw materials remains the major concern for the industry owing to increasing chromium demand for other applications. Prices of raw materials are more likely to affect the profit margins of chromium phosphate manufacturers, with minor price fluctuations also having significant impact on profit margins in the industry. At present, installed capacity for the production of chromium phosphate is very comparatively small, which has resulted in a demand supply gap. Moreover, manufacturing of chromium phosphate is capital intensive.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/chromium-phosphate-industry

Further key findings from the study suggest:

Global chromium phosphate market volumes were estimated at 25,672.1 tons in 2012 and are expected to reach 51,363.2 tons in 2020, growing at a CAGR of 9.1% from 2013 to 2020
Architectural coating applications dominated demand in 2012, accounting for over 42% of global volumes. Chromium phosphate demand for architectural coatings is expected to reach 21,663.5 tons by 2020
Chromium phosphate coatings are being increasingly used in conversion coatings to provide outstanding corrosion protection on aluminum, as well as excellent adhesion properties under organic coatings. Chromium phosphate market revenue for corrosion inhibitor coatings is expected to reach USD 25.35 million by 2020, growing at a CAGR of 10.3% from 2013 to 2020
Medical applications are expected to be the most attractive avenue for chromium phosphate manufacturers, with volume demand estimated to grow at a CAGR of 10% from 2013 to 2020
Key manufacturers and suppliers of chromium phosphate include Chemetall Inc., AK Scientific, Inc., City Chemicals Corporation, and MP Biomedicals, Leancare Ltd. and so on. Distribution is a key success factor in the chromium phosphate industry. Sigma Aldrich, Chemos and Service Chemical Incorporation are some of the leading distributors in this market